Steve H. Kanzer is a businessman with over 20 years of experience in biotechnology and pharmaceutical finance, development, licensing, and mergers and acquisition. He is the longtime chairman and CEO of Accredited Ventures, Inc., and Accredited Equities, Inc., in New York City. Steve Kanzer built his successful career after attending the City University of New York as a Baruch Scholar, eventually graduating magna cum laude and first in his class in 1985.
The Baruch Scholar Program benefits incoming freshmen, providing full tuition for four years based on academic merit. Students are admitted into a rigorous program with a special focus on success in a global economy, growing in professionalism, civic responsibility, and cross-cultural awareness. Throughout their studies, students will pursue their interests and career goals. Study-abroad programs, mandatory community service, and the opportunity to perform independent research are also benefits of becoming a Baruch Scholar.
To learn more about attending the City University of New York as a Baruch Scholar, visit blogs.baruch.cuny.edu/honors/programs/baruch-scholars.
The Baruch Scholar Program benefits incoming freshmen, providing full tuition for four years based on academic merit. Students are admitted into a rigorous program with a special focus on success in a global economy, growing in professionalism, civic responsibility, and cross-cultural awareness. Throughout their studies, students will pursue their interests and career goals. Study-abroad programs, mandatory community service, and the opportunity to perform independent research are also benefits of becoming a Baruch Scholar.
To learn more about attending the City University of New York as a Baruch Scholar, visit blogs.baruch.cuny.edu/honors/programs/baruch-scholars.